We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

PTC Therapeutics Announces $25 Million Award from Cystic Fibrosis Foundation Therapeutics

Expanded collaboration supports pivotal Phase 2b clinical trials of first potential therapy to address an underlying cause of cystic fibrosis.
News

Affymetrix and Asuragen Sign Agreement to Develop IVT Reagent Kits for Molecular Diagnostic Applications

The IVT reagent kits developed by Asuragen are expected to enable Affymetrix to deliver a complete solution to its molecular diagnostic partners.
News

Stanford Researchers Find Molecule that Kills Kidney Cancer Cells

A drug created from this newly found molecule would help fight the life-threatening disease while leaving patients’ kidneys intact, researchers say.
News

OLIGOMERIX Funded by the Alzheimer's Drug Discovery Foundation to Evaluate Compounds Active against Tau Oligomers

OLIGOMERIX will select compounds using its Alzheimer’s disease screening assays and will evaluate these compounds in a tauopathy mouse model.
News

Horizon Discovery Commissioned to Find Drug Candidates by European Stem Cell Consortium

The 12 month program will see Horizon screen a compound library for agents that selectively kill cell-types harboring genes that are found to be activated in cancer stem cells.
News

MedTrust Online Collaborates with Oracle and Dell to Provide Oncologists with Tool for Personalized Care Delivery

The collaboration will bring the new discoveries across health sciences to Oncologists at South Texas Oncology and Hematology.
News

MolecularMD Licenses Patented IP Related to the Detection of Imatinib Resistant BCR-ABL Mutations

The company signs license agreement with the Oregon Health & Science University to obtain exclusive commercial rights to patented intellectual property.
News

Daiichi Sankyo Co. Announces Acquisition of Biotech Firm U3 Pharma AG

Daiichi enters agreement to acquire the privately held German biotechnology company focusing on research into antibodies for the treatment of cancer.
News

Accelr8 and BD Sign Research and Licensing Option Agreement

BD commercializes Accelr8’s BACcel™ rapid diagnostics technology.
News

Molecular 'Clock' Could Predict Risk for Developing Breast Cancer

A chemical reaction in genes that control breast cancer provides a molecular clock that could accurately predict woman’s risk for developing breast cancer.
Advertisement